This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by González, G. M.
Right arrow Articles by Rinaldi, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by González, G. M.
Right arrow Articles by Rinaldi, M. G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2001, p. 633-635, Vol. 45, No. 2
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.2.633-635.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

In Vitro Activities of Approved and Investigational Antifungal Agents against 44 Clinical Isolates of Basidiomycetous Fungi

Gloria M. González,1,2,* Deanna A. Sutton,1 Elizabeth Thompson,1 Rolando Tijerina,2 and Michael G. Rinaldi1,3

Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center at San Antonio,1 and Audie L. Murphy Division, South Texas Veterans Health Care System,3 San Antonio, Texas 78229-3900, and Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México2

Received 21 August 2000/Returned for modification 3 October 2000/Accepted 20 November 2000

The in vitro activity of amphotericin B, fluconazole, flucytosine, itraconazole, voriconazole, and posaconazole was evaluated against 44 clinical isolates of filamentous basidiomycetous fungi. No statistically significant differences were noted between Schizophyllum commune (n = 5), Coprinus species (n = 8), Bjerkandera adusta (n = 14), and sterile, uncharacterized basidiomycetes (n = 17).

* Corresponding author. Mailing address: Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900. Phone: (210) 567-4131. Fax: (210) 567-4076. E-mail: gonzalezg{at}uthscsa.edu.

Antimicrobial Agents and Chemotherapy, February 2001, p. 633-635, Vol. 45, No. 2
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.2.633-635.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Mori, T., Seki, A., Kano, R., Sakai, H., Nakagawa, M., Hasegawa, A., Maruo, K. (2009). Mycotic osteomyelitis caused by Schizophyllum commune in a dog. Vet Rec. 165: 350-351 [Full Text]  
  • van de Sande, W. W. J., Luijendijk, A., Ahmed, A. O. A., Bakker-Woudenberg, I. A. J. M., van Belkum, A. (2005). Testing of the In Vitro Susceptibilities of Madurella mycetomatis to Six Antifungal Agents by Using the Sensititre System in Comparison with a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5- [(Phenylamino)Carbonyl]-2H-Tetrazolium Hydroxide (XTT) Assay and a Modified NCCLS Method. Antimicrob. Agents Chemother. 49: 1364-1368 [Abstract] [Full Text]  
  • Sutton, D. A., Thompson, E. H., Rinaldi, M. G., Iwen, P. C., Nakasone, K. K., Jung, H. S., Rosenblatt, H. M., Paul, M. E. (2005). Identification and First Report of Inonotus (Phellinus) tropicalis as an Etiologic Agent in a Patient with Chronic Granulomatous Disease. J. Clin. Microbiol. 43: 982-987 [Abstract] [Full Text]  
  • Courtney, R., Pai, S., Laughlin, M., Lim, J., Batra, V. (2003). Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults. Antimicrob. Agents Chemother. 47: 2788-2795 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»